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background: Silent cerebral lesions (SCL) have been identified on magnetic resonance imaging (MRI) in asymptomatic patients after atrial 
fibrillation (AF) ablation. SCL represent irreversible cerebral damage, comparative analysis using a consistent MRI definition is missing and factors 
influencing the risk of SCL are poorly understood.
methods: 297 Patients undergoing AF ablation underwent post-ablation cerebral MRI. SCL were identified based on a sensitive definition using 
a 1.5Tesla MRI including DWI and ADC-map (but not including FLAIR). AF ablation was performed either using irrigated single-tip radiofrequency 
(RF) ablation (group 1, N=44), phased RF pulmonary vein isolation (PVI) (group 2, N=129), PVI plus additional phased RF ablation of left atrial 
fractionated electrogram sites using multipolar catheters (group 3, N=13), endoscopically-guided laser balloon (group 4, N=27), cryo-balloon PVI 
(group 5, N=34) and irrigated RF multipolar catheters (nMARQ) (group 6, N=50). Differences in regard to SCL rates were analyzed. 
results: In group 1 20%, in group 2 37%, in group 3 87%, in group 4 37%, in group 5 21% and in group 6 32% of patients had documented SCL. 
The incidence of SCL was significantly higher in group 3 patients compared to all other groups. There was a significantly higher incidence of SCL in 
patients with compared to without exchanges of catheters over a single transseptal sheath (34% vs. 18%, p=0.007) and in patients with left atrial 
dilation (48% vs. 30%, p=0.01). In a subgroup analysis incidence of SCL was lower when patients were ablated under continued oral anticoagulation 
(11%) compared to novel oral anticoagulants (33%) or without continuous appropriate anticoagulation bridged with low-molecular weight heparin 
(45%).
conclusions: When using a sensitive MRI definition of SCL incidences are relevantly higher compared to using the “old” definition including the 
FLAIR-sequence. Technology-associated and procedural characteristics associated with a higher risk of SCL have been identified. Modification of 
procedural steps of the AF ablation procedure may further reduce the risk of SCL.
